Biospecimen sharing among Hispanic women in a safety-net clinic: Implications for the precision medicine initiative

Journal of the National Cancer Institute

Volumn 109, Issue 2, 2017, Pages

  Nodora, Jesse N ^a,b   Komenaka, Ian K ^c   Bouton, Marcia E ^c   Ohno Machado, Lucila ^b   Schwab, Richard ^a   Kim, Hyeon Eui ^b   Farcas, Claudiu ^b   Perez, Giovanna ^a   Martinez, Maria Elena ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MARICOPA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOBANK; BREAST BIOPSY; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HEALTH LITERACY; HISPANIC; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; PERCEPTION; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY NET HOSPITAL; SCIENTIST; BIOPSY; BREAST; COOPERATION; INFORMATION DISSEMINATION; INFORMED CONSENT; MIDDLE AGED; PATHOLOGY; RANDOMIZATION; VULNERABLE POPULATION;

ADULT; BIOLOGICAL SPECIMEN BANKS; BIOPSY; BREAST; COOPERATIVE BEHAVIOR; FEMALE; HISPANIC AMERICANS; HUMANS; INFORMATION DISSEMINATION; INFORMED CONSENT; MIDDLE AGED; PRECISION MEDICINE; RANDOM ALLOCATION; SAFETY-NET PROVIDERS; VULNERABLE POPULATIONS;

EID: 85018203460     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djw201     Document Type: Article

References (15)

1. Glied S, Lleras-Muney A. Technological innovation and inequality in health. Demography. 2008;45(3):741-761.
2. Partridge EE. Yes, minority and underserved populations will participate in biospecimen collection. Cancer Epidemiol Biomarkers Prev. 2014;23(6):895-897.
3. Lopez DS, Fernandez ME, Cano MA, et al. Association of acculturation, nativity, and years living in the United States with biobanking among individuals of Mexican descent. Cancer Epidemiol Biomarkers Prev. 2014;23(3):402-408.
4. Martin DN, Lam TK, Brignole K, et al. Recommendations for cancer epidemiologic research in understudied populations and implications for future needs. Cancer Epidemiol Biomarkers Prev. 2016;25(4):573-580.
5. Knerr S, Ceballos RM. Giving samples or "getting checked": Measuring conflation of observational biospecimen research and clinical care in Latino communities. BMC Med Ethics. 2015;16(1):1.
6. Loffredo CA, Luta G, Wallington S, et al. Knowledge and willingness to provide research biospecimens among foreign-born Latinos using safety-net clinics. J Comm Health. 2013;38(4):652-659.
7. Komenaka IK, Nodora JN, Hsu CH, et al. Association of health literacy with adherence to screening mammography guidelines. Obstet Gynecol. 2015; 125(4):852-859.
8. Moore HM, Compton CC, Lim MD, et al. 2009 Biospecimen research network symposium: Advancing cancer research through biospecimen science. Cancer Res. 2009;69(17):6770-6772.
9. Vaught JB, Lockhart N, Thiel KS, et al. Ethical, legal, and policy issues: Dominating the biospecimen discussion. Cancer Epidemiol Biomarkers Prev. 2007; 16(12):2521-2523.
10. Hohl SD, Gonzalez C, Carosso E, et al. I did it for us and I would do it again: Perspectives of rural latinos on providing biospecimens for research. Am J Public Health. 2014;104(5):911-916.
11. Gabriel A, Cohen CC, Sun C. Consent to specimen storage and continuing studies by race and ethnicity: A large dataset analysis using the 2011-2012 National Health and Nutrition Examination Survey. Sci World J. 2014;2014: 120891.
12. Colby SL, Ortman, Jennifer M. Projections of the size and composition of the U.S Population: 2014 to 2060. Current Population Reports. Washington, DC: U.S. Census Bureau; 2014:25-1143.
13. Hawk ET, Habermann EB, Ford JG, et al. Five National Cancer Institutedesignated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: A current view and opportunities for improvement. Cancer. 2014;120(suppl 7):1113-1121.
14. Chen MS Jr, Lara PN, Dang JH, et al. Twenty years post-NIH Revitalization Act: Enhancing minority participation in clinical trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrual: Eenewing the case for enhancing minority participation in cancer clinical trials. Cancer. 2014; 120(suppl 7):1091-1076.
15. Bustamante CD, Burchard EG, De la Vega FM. Genomics for the world. Nature. 2011;475(7355):163-165.